Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade

Published:2016-03 Issue:3 Volume:29 Page:285-296
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Tang Haidong,Wang Yang,Chlewicki Lukasz K.,Zhang Yuan,Guo Jingya,Liang Wei,Wang Jieyi,Wang Xiaoxiao,Fu Yang-Xin

Funder

National Cancer Institute

AbbVie

Chinese Academy of Sciences

Chinese Ministry of Science and Technology

Cancer Research Institute Irvington Fellowship

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference58 articles.

1. Immune checkpoint combinations from mouse to man;Ai;Cancer Immunol. Immunother.,2015

2. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells;Blank;Cancer Res.,2004

3. Yeast surface display for screening combinatorial polypeptide libraries;Boder;Nat. Biotechnol.,1997

4. Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients;Boussemart;Ann. Oncol.,2013

5. Safety and activity of anti–PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12

2. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

3. Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC;Scientific Reports;2024-09-13

4. Tertiary lymphoid structures in anticancer immunity;Nature Reviews Cancer;2024-08-08

5. Exploring potential predictive biomarkers through historical perspectives on the evolution of systemic therapies into the emergence of neoadjuvant therapy for the treatment of hepatocellular carcinoma;Frontiers in Oncology;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3